DNA replication—which happens when cells divide—is one of the most important processes in all living organisms. In a landmark finding, published today in Cell, scientists identified a multi-protein “machine” in cells that helps govern the pausing or stopping of DNA replication to ensure its smooth progress.
Less than 10% of funding for health research goes towards health in lower-resource countries, where 90% of preventable deaths occur. Epilepsy research faces similar challenges to research in other health conditions, but also some unique issues.
Artist Syril Strickler was 47 when she had her first epileptic seizure, waking up in the hospital after neighbors found her unconscious in the street. For 10 years, seizures every few weeks brought her life to a virtual standstill—until Cedars-Sinai physicians performed a surgery that gave Strickler her life back.
Seizures are different in newborns. Dr. Emma Carter speaks with Dr. Ronit Pressler about recent guidelines and recommendations for treating seizures in newborns and how they were established.
Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased to announce that it has entered into an exclusive licensing agreement with Sovargen Co., Ltd, a biotechnology company specializing in central nervous system (CNS) diseases, to develop, manufacture and commercialise paxalisib as a potential treatment of intractable epilepsy in focal cortical dysplasia type 2 (FCD T2) and tuberous sclerosis complex (TSC) disease.
Dana-Farber Cancer Institute launched the Neuro-Inclusive Oncology Care and Empowerment Program, a psychosocial oncology program that is specialized for adults with intellectual and/or developmental disabilities (IDD).
Although 80% of people with epilepsy live in low- and middle-income countries (LMICs), most epilepsy research originates in high-income regions.
Genetic testing has become a more common way to diagnose and manage many neurologic conditions including dementia, Parkinson’s disease and epilepsy, but a new study has found not everyone may have the same level of access to these tests. Black people were half as likely as white people to be evaluated for genetic testing, according to a study published in the March 6, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
In the mid-1990s, Dr. Edward (Ted) Reynolds, then president of ILAE, recognized that epilepsy required global solutions. His ideas blossomed into the Global Campaign Against Epilepsy and established partnerships between ILAE, the World Health Organization, and the International Bureau for Epilepsy.
A special session at the American Epilepsy Society meeting in December 2023 reviewed progress on the Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders (IGAP) and discussed strategies for moving forward.
For people with drug-resistant epilepsy, having a dog companion trained in detecting seizures and other epilepsy-related tasks may reduce the amount of seizures they have, according to new research published in the February 28, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. For the study, researchers looked at adults with severe epilepsy who have been unable to find effective treatment to reduce seizures.
Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.
For people with epilepsy, driving is a top concern. The inability to drive often comes with frustration, a loss of freedom, and dependency on others. Regulations vary; some countries ban people with epilepsy from driving for life, while most require a specific seizure-free period.
Diagnosed with epilepsy at age 10, Torie Robinson uses her podcast to share knowledge with people with epilepsy, their families, and the public. Her episode topics range from the biochemistry of epilepsy to gastrointestinal issues and much, much more.
Aunque la cirugía puede ser una opción para hasta el 40% de las personas con epilepsia resistente a los medicamentos, menos del 1% son remitidos a centros de epilepsia cada año. ¿Por qué?
Surgery may be an option for up to 40% of people with drug-resistant epilepsy, but fewer than 1% are referred to epilepsy centers each year. Why?
In a detailed, comprehensive, and scholarly fashion, the writer takes us on a journey, using the metaphor of “The Voyage of the Good Ship Epilepsy." As a near footnote, the author suggests in the end that the term "epilepsy" should be abolished altogether.
The latest research and expertise on the flue can be found in the Influenza channel on Newswise.
Después de inventar el primer sostén deportivo comercial en la década de 1970, Lisa Lindahl aprovechó su perspectiva única como líder empresarial con epilepsia para aumentar la financiación de la investigación y la concienciación sobre los problemas relacionados con la epilepsia en las mujeres.
The death rate for patients with functional, nonepileptic seizures is higher than expected, with a rate comparable to epilepsy and severe mental illness, a Michigan Medicine-led study finds.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right